Valeant Continues Its Expansion With Acquisition Of PharmaSwiss
This article was originally published in The Pink Sheet Daily
Deal will add commercial infrastructure in Central and Eastern Europe and provide tax benefits.
You may also be interested in...
Merger and acquisition talk was flying during the week of April 2, while some smaller deals actually got signed on the dotted line.
Stada spends $537 million on Grünenthal's branded product portfolio in Central and Eastern Europe and Spirig's generics business in Switzerland.
Drug Facts Box format scored well in a broad study, but researchers found it may not be the best format for everyone.